Item scores for guides and factsheets based on the modified NHMRC and iCAHE appraisal tool
| Resource reference | Item 1 | Item 2 | Item 3 | Item 4a | Item 4b* | Item 5 | Item 6 | Item 7 | Item 8 |
| American Academy of Pediatrics 202273 | C | C | A | B | B | A | A | A | A |
| Bartlett and Davis74 | C | B | A | B | B | B | D | A | B |
| British Medical Association 200775 | B | B | A | B | B | A | A | A | A |
| Brown et al 201876 | B | B | A | B | B | A | A | A | B |
| Chudley and Longstaffe77 | B | B | A | B | B | A | C | A | A |
| Dudley et al 201678 | D | B | A | A | A | A | B | A | B |
| FASD Hub Australia 201979 | B | B | A | A | B | A | A | A | A |
| US DHHS, CDC 201580 | B | B | A | B | B | A | B | A | A |
| Fleming 199981 | B | B | A | B | B | A | D | A | A |
| FARE n.d.82 | B | C | A | A | A | A | D | A | A |
| Gray and Mukherjee83 | B | C | A | B | B | A | C | D | A |
| Hagan et al 201684 | B | C | A | B | B | A | B | A | A |
| Hanlon-Dearman et al 201585 | B | B | A | A | B | A | B | A | A |
| Burd 201386 | B | C | A | B | B | A | B | A | A |
| Canada Northwest FASD Partnership 201687 | D | B | A | B | B | A | A | A | B |
| Martyniuk and Melrose88 | C | C | A | B | B | A | A | A | A |
| Ozsarfati and Koren89 | B | B | A | B | B | A | B | A | B |
| Peadon and Elliott90 | B | B | A | A | A | A | B | A | A |
| Seashell and NOFASD UK 202091 | B | B | A | B | B | A | A | A | A |
| Sokol and Clarren92 | B | D | A | B | B | A | D | A | B |
| Todorow et al 201293 | B | C | A | B | B | A | C | A | A |
| Wilton and Plane94 | B | C | A | B | B | A | D | A | B |
| Cannon et al 202095 | B | C | A | A | A | A | A | A | B |
| Cannon et al 202096 | B | C | A | A | A | A | A | A | B |
| Kippin et al 202097 | B | C | A | A | A | A | A | A | B |
| Green et al 200198 | B | C | A | B | B | B | D | D | A |
| Huggins et al 200899 | B | C | A | B | B | A | C | D | A |
| Nash and Davies100 | B | C | A | B | B | A | B | C | B |
| NOFASD Australia101 | D | C | A | A | B | A | A | A | B |
| NOFASD Australia102 | D | C | A | A | B | A | A | A | A |
| NOFASD Australia103 | D | C | A | A | B | A | A | A | A |
| Rutman 2016104 | B | C | A | B | B | A | B | A | A |
Item 1: evidence base; item 2: clinical impact; item 3: generalisability to health professionals working with FASD; item 4a: applicability to patient populations—Australia; item 4b: applicability to patient populations—First Nations Australians; item 5: availability; item 6: timing and updates/review (currency); item 7: ease of use; item 8: credibility.
Scores: A=excellent; B=good; C=satisfactory; D=poor.
*Scores for item 4b were not included in overall scores.
CDC, Centers for Disease Control and Prevention; FARE, Foundation for Alcohol Research and Education; FASD, fetal alcohol spectrum disorder; n.d, no date; NHMRC, National Health and Medical Research Council; USDHHS, US Department of Health and Human Services.